AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment
Authors: Pugatch, DL Levesque, BG Lally, MA Reinert, SE Filippone, WJ Combs, CM Flanigan, TP Brown, LK
Citation: Dl. Pugatch et al., HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment, J ACQ IMM D, 27(2), 2001, pp. 135-142
Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998
Authors: Murphy, EL Assmann, SF Collier, AC Flanigan, TP Kumar, PN Wallach, FR Krubel, S
Citation: El. Murphy et al., Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998, CLIN INF D, 32(1), 2001, pp. 116-123
Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial
Authors: Collier, AC Kalish, LA Busch, MP Gernsheimer, T Assmann, SF Lane, TA Asmuth, DM Lederman, MM Murphy, EL Kumar, P Kelley, M Flanigan, TP McMahon, DK Sacks, HS Kennedy, MS Holland, PV
Citation: Ac. Collier et al., Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial, J AM MED A, 285(12), 2001, pp. 1592-1601
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
Authors: Murphy, EL Collier, AC Kalish, LA Assmann, SF Para, MF Flanigan, TP Kumar, PN Mintz, L Wallach, FR Nemo, GJ
Citation: El. Murphy et al., Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease, ANN INT MED, 135(1), 2001, pp. 17-26
Modified wick method using Weck-Cel sponges for collection of human rectalsecretions and analysis of mucosal HIV antibody
Authors: Kozlowski, PA Lynch, RM Patterson, RR Cu-Uvin, S Flanigan, TP Neutra, MR
Citation: Pa. Kozlowski et al., Modified wick method using Weck-Cel sponges for collection of human rectalsecretions and analysis of mucosal HIV antibody, J ACQ IMM D, 24(4), 2000, pp. 297-309
Comprehensive medical care among HIV-positive incarcerated women: The Rhode Island experience
Authors: Farley, JL Mitty, JA Lally, MA Burzynski, JN Tashima, K Rich, JD Cu-Uvin, S Spaulding, A Normandie, L Snead, M Flanigan, TP
Citation: Jl. Farley et al., Comprehensive medical care among HIV-positive incarcerated women: The Rhode Island experience, J WOMEN H G, 9(1), 2000, pp. 51-56
Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection
Authors: Hewitt, RG Yiannoutsos, CT Higgs, ES Carey, JT Geiseler, PJ Soave, R Rosenberg, R Vazquez, GJ Wheat, LJ Fass, RJ Antoninievic, Z Walawander, AL Flanigan, TP Bender, JF
Citation: Rg. Hewitt et al., Paromomycin: No more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection, CLIN INF D, 31(4), 2000, pp. 1084-1092
Antiretroviral therapy in the year 2000
Authors: Tashima, KT Flanigan, TP
Citation: Kt. Tashima et Tp. Flanigan, Antiretroviral therapy in the year 2000, INF DIS CL, 14(4), 2000, pp. 827
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA
Authors: Cu-Uvin, S Caliendo, AM Reinert, S Chang, A Juliano-Remollino, C Flanigan, TP Mayer, KH Carpenter, CCJ
Citation: S. Cu-uvin et al., Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA, AIDS, 14(4), 2000, pp. 415-421
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface
Authors: Shacklett, BL Cu-Uvin, S Beadle, TJ Pace, CA Fast, NM Donahue, SM Caliendo, AM Flanigan, TP Carpenter, CCJ Nixon, DF
Citation: Bl. Shacklett et al., Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface, AIDS, 14(13), 2000, pp. 1911-1915
Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease
Authors: Kalish, LA Collier, AC Flanigan, TP Kumar, PN
Citation: La. Kalish et al., Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease, J INFEC DIS, 182(2), 2000, pp. 603-606
Laboratory testing for infection with the human immunodeficiency virus: Established and novel approaches
Authors: Mylonakis, E Paliou, M Lally, M Flanigan, TP Rich, JD
Citation: E. Mylonakis et al., Laboratory testing for infection with the human immunodeficiency virus: Established and novel approaches, AM J MED, 109(7), 2000, pp. 568-576
Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island
Authors: Rich, JD Dickinson, BP Macalino, G Flanigan, TP Towe, CW Spaulding, A Vlahov, D
Citation: Jd. Rich et al., Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island, J ACQ IMM D, 22(2), 1999, pp. 161-166
Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
Authors: Dong, KL Bausserman, LL Flynn, MM Dickinson, BP Flanigan, TP Mileno, MD Tashima, KT Carpenter, CCJ
Citation: Kl. Dong et al., Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART), J ACQ IMM D, 21(2), 1999, pp. 107-113
Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning
Authors: Vigilante, KC Flynn, MM Affleck, PC Stunkle, JC Merriman, NA Flanigan, TP Mitty, JA Rich, JD
Citation: Kc. Vigilante et al., Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning, J WOMENS HE, 8(3), 1999, pp. 409-415
Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection
Authors: Flanigan, TP Hogan, JW Smith, D Schoenbaum, E Vlahov, D Schuman, P Mayer, K
Citation: Tp. Flanigan et al., Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection, CLIN INF D, 29(3), 1999, pp. 608-612
Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis
Authors: Mylonakis, E Merriman, NA Rich, JD Flanigan, TP Walters, BC Tashima, KT Mileno, MD van der Horst, CM
Citation: E. Mylonakis et al., Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis, DIAG MICR I, 34(2), 1999, pp. 111-114
HIV care among incarcerated persons: a missed opportunity
Authors: Flanigan, TP Rich, JD Spaulding, A
Citation: Tp. Flanigan et al., HIV care among incarcerated persons: a missed opportunity, AIDS, 13(17), 1999, pp. 2475-2476
Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C
Authors: Ahmad, M Tashima, KT Caliendo, AM Flanigan, TP
Citation: M. Ahmad et al., Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C, AIDS, 13(10), 1999, pp. 1281-1282
Abscess related to anabolic-androgenic steroid injection
Authors: Rich, JN Dickinson, BP Flanigan, TP Valone, SE
Citation: Jn. Rich et al., Abscess related to anabolic-androgenic steroid injection, MED SCI SPT, 31(2), 1999, pp. 207-209
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
Authors: Tashima, KT Caliendo, AM Ahmad, M Gormley, JM Fiske, WD Brennan, JM Flanigan, TP
Citation: Kt. Tashima et al., Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy, J INFEC DIS, 180(3), 1999, pp. 862-864
CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection
Authors: Williams, SB Flanigan, TP Artenstein, AW VanCott, TC Smith, D Mayer, K Koup, RA
Citation: Sb. Williams et al., CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection, J INFEC DIS, 179(5), 1999, pp. 1310-1312
Mucosal vaccination strategies for women
Authors: Kozlowski, PA Cu-Uvin, S Neutra, MR Flanigan, TP
Citation: Pa. Kozlowski et al., Mucosal vaccination strategies for women, J INFEC DIS, 179, 1999, pp. S493-S498
Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites
Authors: Nanduri, J Williams, S Aji, T Flanigan, TP
Citation: J. Nanduri et al., Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites, INFEC IMMUN, 67(4), 1999, pp. 2022-2024
Misdiagnosis of HIV infection - Response
Authors: Rich, JD Mylonakis, E Flanigan, TP
Citation: Jd. Rich et al., Misdiagnosis of HIV infection - Response, ANN INT MED, 131(7), 1999, pp. 547-548
Risultati: 1-25 | 26-28